at 10
intrapharm laboratories limited - dihydrotachysterol - oral drops solution - 250 microgram/ml - dihydrotachysterol
at10 250micrograms/ml oral solution
esteve pharmaceuticals ltd - dihydrotachysterol - oral solution - 250microgram/1ml
hytakerol capsule
sanofi-synthelabo canada inc - dihydrotachysterol - capsule - .125mg - dihydrotachysterol .125mg - vitamin d
tachyrol tablets 0.2 milligram
abbott healthcare products ltd - dihydrotachysterol - tablets - 0.2 milligram
cal.d.forte
psm healthcare ltd trading as api consumer brands - colecalciferol 1.25mg equivalent to 50,000 iu (plus 12% (0.15 mg) overage) - coated tablet - 1.25 mg - active: colecalciferol 1.25mg equivalent to 50,000 iu (plus 12% (0.15 mg) overage) excipient: acacia ammonia solution calcium carbonate castor oil ether gelatin hydrated silica lactose monohydrate magnesium stearate maize starch methylated spirits povidone powdered cellulose prepared theobroma purified talc purified water shellac sucrose titanium dioxide white beeswax - indicated for treatment of vitamin d deficiency associated with malabsorption in children and/or adult patients. indicated for prevention and treatment of vitamin d deficiency states.
apo-levothyroxine levothyroxine sodium 200 microgram un-coated tablet blister pack
southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.
levothyroxine lup levothyroxine sodium 200 microgram un-coated tablet blister pack
southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.
apo-levothyroxine levothyroxine sodium 150 microgram un-coated tablet blister pack
southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.15 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.
levothyroxine lup levothyroxine sodium 150 microgram un-coated tablet blister pack
southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.15 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.
apo-levothyroxine levothyroxine sodium 125 microgram un-coated tablet blister pack
southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.125 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.